Safe Use of FOLFOX in Two Patients With Metastatic Colorectal Carcinoma and Severe Hepatic Dysfunction
- 1 March 2011
- journal article
- case report
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 10 (1), E6-E9
- https://doi.org/10.3816/ccc.2011.n.011
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cisplatin as Single-Agent Chemotherapy in Patients with Liver Dysfunction Due to MetastasesOnkologie, 2009
- Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastasesBMC Cancer, 2008
- Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group StudyClinical Cancer Research, 2007
- Extended Resections of Liver Metastases from Colorectal CancerWorld Journal of Surgery, 2007
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunctionAnnals of Oncology, 2003
- Dosage Adjustment and Pharmacokinetic Profile of Irinotecan in Cancer Patients With Hepatic DysfunctionJournal of Clinical Oncology, 2002
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancerCancer, 1994
- Cytostatic Drug Therapy in Disseminated Colorectal CancerScandinavian Journal of Gastroenterology, 1988